CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
Abstract Background Tregs are key drivers of immunosuppression in solid tumors. As an important chemokine receptor on Tregs, the regulatory effect of CCR8 on tumor immunity has received more and more attention. However, the current research on CCR8 in the immune microenvironment of ovarian cancer ha...
Main Authors: | Shuna Liu, Ziqi Tao, Jianfang Lou, Rong Li, Xin Fu, Juan Xu, Ting Wang, Lei Zhang, Wenwen Shang, Yepeng Mao, Fang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04686-3 |
Similar Items
-
Chemokine Receptor-Targeted Therapies: Special Case for CCR8
by: Bernhard Moser
Published: (2022-01-01) -
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01) -
Glucose metabolism and function of CD4+ Tregs are regulated by the TLR8/mTOR signal in an environment of SKOV3 cell growth
by: Ming Wu, et al.
Published: (2023-08-01) -
Circulating CD4<sup>+</sup> Treg, CD8<sup>+</sup> Treg, and CD3<sup>+</sup> γδ T Cell Subpopulations in Ovarian Cancer
by: Rong Li, et al.
Published: (2023-01-01) -
Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
by: S. Bowler, et al.
Published: (2019-09-01)